From the May issue—
Tsyn-Seq: a T-cell Synapse–Based Antigen Identification Platform, by Yimei Jin et al.
bit.ly/3UEX8d4
MD Anderson Cancer Center

From the May issue—
Chronic Stress Exacerbates the #Immunosuppressive Microenvironment and Progression of #Gliomas by Reducing Secretion of CCL3, by Xu Wang et al.
bit.ly/3JUg4Qr

Stay up to date with the latest Cancer Immunology Research #OnlineFirst articles.
bit.ly/3WyIqHt

In the Spotlight from the May issue—
Living in Syn: T Cell Antigen Identification Based on Synapse Sequencing, by Venkata Krishna Kanth Makani and Alok Joglekar.
bit.ly/3QC0Bbd
PittDeptofMed

In the Spotlight from the May issue—
Stressing the Role of CCL3 in Reversing the #Immunosuppressive Microenvironment in #Gliomas , by Xiaoteng Cui and Chunsheng Kang.
bit.ly/44vPNRS

During her talk, Polyak Lab is sharing mechanisms of immune escape and response to #immunotherapy in a preclinical model of #BreastCancer . Additional information can be found in Cancer Immunology Research: aacrjournals.org/cancerimmunolr… #SMC3B #BCSM

The Alspach Lab's 🥇 research article is online now Cancer Immunology Research! By interrogating publicly available scRNA-seq datasets, we identified #sexdifferences in T cell CXCL13 expression, and CXCL13 association with antiPD-1 response in lung cancer.

aacrjournals.org/cancerimmunolr…

New from the April issue—
Gut Mycobiota Dysbiosis Is Associated with #Melanoma and Response to Anti–PD-1 Therapy, by Natalia Szóstak et al.
bit.ly/3xZJHNt

New from the April issue—
Neutrophils Mediate Protection Against Colitis and Carcinogenesis by Controlling Bacterial Invasion and IL22 Production by γδ T Cells, by Silvia Carnevale et al.
bit.ly/4dmf0SA
Humanitas Milano

New Priority Brief from the April issue—
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by #Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy, by Jiang Chen et al.
bit.ly/3UCPGjU
MassGeneral Medicine

Congratulations to Steven A. Rosenberg, MD, PhD, and colleagues, recipients of the inaugural Cancer Immunology Research Award for Outstanding Journal Article! Learn more about this award:
bit.ly/3UCe6u1
#AACR24

New in Rising Stars in Cancer Immunology, from the April issue—
CD4+ Regulatory T Cells in Human Cancer: Subsets, Origin, and Molecular Regulation, by Julian Swatler, Lugli Lab et al.
bit.ly/3JxDH10
Humanitas Milano

Read a commentary from the April issue—
NCI Resources for Cancer Immunoprevention Research, by Shizuko Sei et al.
bit.ly/49NpTKm
National Cancer Institute

Read an In the Spotlight article from the April issue—
Allogeneic CAR T Cells: Complex Cellular Therapy Designs Test the Limits of Our Preclinical Models, by Paolo F. Caimi and J. Joseph Melenhorst, PhD.
bit.ly/3xJofw9

Read an In the Spotlight article from the April issue—
Immunomodulatory Effects of RANK/RANKL Blockade in Patients with Cancer, by Elham Nasrollahi and Diwakar Davar, M.D..
bit.ly/3QamH4o
UPMC Hillman Cancer Center

Read an In the Spotlight article from the April issue—
Optimal Neoantigen Cancer Vaccines Target CD8+ and CD4+ T Cells with Multiple Antigens, by Craig Slingluff.
bit.ly/3Umlolp

Cancer Immunology Research's 'What We're Reading' highlights articles recently published in the field and are selected by our Senior and Deputy Editors.
Check out this month's list—
bit.ly/4aCTyHr

Thanks ACIR for highlighting our work on #TREX1 , which is online in Cancer Immunology Research alongside complementary findings from Eleonore Toufektchan and John Maciejowski

If you enjoyed the #AACR24 Major Symposium on Engineering strategies based on NK and gd T cells, be sure to check out this paper on the topic.
bit.ly/3JcD50j AACR